Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry

Journal of Proteome Research

Volumn 4, Issue 2, 2005, Pages 377-386

  DeSouza, Leroi ^a   Diehl, Georg ^a   Rodrigues, Mary Joe ^b   Guo, Jingzhong ^a   Romaschin, Alexander D ^c,d   Colgan, Terence J ^b,d   Siu, K W Michael ^a  

^a YORK UNIVERSITY   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

cICAT; Endometrial cancer markers; iTRAQ; Liquid chromatography; Tandem mass spectrometry

Indexed keywords

ALPHA 1 ANTITRYPSIN; CHAPERONIN; CREATINE KINASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; PYRUVATE KINASE; SECRETORY COMPONENT; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; DESORPTION; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; SURFACE PROPERTY; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

CHROMATOGRAPHY, LIQUID; ENDOMETRIAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; MASS SPECTROMETRY; SENSITIVITY AND SPECIFICITY;

EID: 17444383113     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr049821j     Document Type: Article

References (46)

1. National Cancer Institute of Canada: Canadian Cancer Statistics 2003, Toronto, Canada, 2003 [Serial online] April 2003; Available from: URL: http://www.bc.cancer.ca/vgn/images/portal/cit_776/61/38/56158640niw_stats_en.pdf
2. Buckley, C. H. Normal endometrium and nonproliferative conditions of the endometrium. In Obstetrical and Gynaecological Pathology, 5th ed.; Fox, H., Wells, M., Eds.; Churchill-Livingstone: London, 2003, pp 391-442.
3. DeSouza, L.; Diehl, G.; Yang, E. C. C.; Guo, J.; Rodrigues, M. J.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. M. Proteomic Analysis of the Proliferative and Secretory Phases of the Human Endometrium: Protein Identification and Differential Protein Expression. Proteomics 2004, 5, 270-281.
4. Yang, E. C. C.; Guo, J.; Diehl, G.; DeSouza, L.; Rodrigues, M. J.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. M. Expression Profiling of Endometrial Malignancies Reveals a New Tumor Marker: Chaperonin 10. J. Proteome Res. 2004, 3, 636-643.
5. Guo, J.; Yang, E. C. C.; DeSouza, L.; Diehl, G.; Rodrigues, M. J.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. M. A Strategy for High-Resolution and Protein Identification in Surface- Enhanced Laser Desorption/Ionization (SELDI) Mass Spectrometry: Calgranulin A and Chaperonin 10 as Protein Markers for Endometrial Carcinoma. Proteomics, accepted.
6. Gygi, S. P.; Rist, B.; Gerber, S. A.; Turecek, F.; Gelb, M. H.; Aebersold, R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17, 994-999.
7. Li, J.; Steen, H.; Gygi, S. P. Protein profiling with cleavable isotope-coded affinity tag (cICAT) reagents. Mol. Cell Proteomics 2003, 2, 1198-1204.
8. Cappello, F.; Bellafiore, M.; David, S.; Anzalone, R.; Zummo, G. Ten kilodalton heat shock protein (HSP10) is overexpressed during carcinogenesis of large bowel and uterine exocervix. Cancer Lett. 2003, 196, 35-81.
9. Fan, X.; Yan, L.; Jia, S.; Ma, A.; Qiao, C. A study of early pregnancy factor activity in the sera of women with trophoblastic tumour. Am. J. Reprod. Immunol. 1999, 41, 204-208.
10. Kim, C. W.; Kim, J. I.; Park, S. H.; Han, J. Y.; Kim, J. K.; Chung, K. W.; Sun, H. S. Usefulness of plasma tumor M2-pyruvate kinase in the diagnosis of gastrointestinal cancer. Korean J. Gastroenterol. 2003, 42, 387-393.
11. Hardt, P. D.; Toepler, M.; Ngoumou, B.; Rupp, J.; Kloer, H. U. Fecal pyruvate kinase concentrations (ELISA based on a combination of clone 1 and clone 3 antibodies) for gastric cancer screening. Anticancer Res. 2003, 23, 855-857.
12. Marshall, M. J.; Goldberg, D. M.; Neal, F. E.; Millar, D. R. Enzymes of glucose metabolism in carcinoma of the cervix and endometrium of the human uterus. Br. J. Cancer. 1978, 37, 990-1001.
13. Tanaka, M.; Adzuma, K.; Iwami, M.; Yoshimoto, K.; Monden, Y.; Itakura, M. Human calgizzarin; one colorectal cancer-related gene selected by a large scale random cDNA sequencing and northern blot analysis. Cancer Lett. 1995, 89, 195-200.
14. Chaurand, P.; DaGue, B. B.; Pearsall, R. S.; Threadgill, D. W.; Caprioli, R. M. Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry. Proteomics 2001, 1, 1320-1326.
15. Blaxall, B. C.; Dwyer-Nield, L. D.; Bauer, A. K.; Bohlmeyer, T. J.; Malkinson, A. M.; Port, J. D. Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol. Carcinog. 2000, 28, 76-83.
16. Gouble, A.; Grazide, S.; Meggetto, F.; Mercier, P.; Delsol, G.; Morello, D. A new player in oncogenesis: AUF1/hnRNPD overexpression leads to tumorigenesis in transgenic mice. Cancer Res. 2002, 62, 1489-1495.
17. Nishihira, J.; Ishibashi, T.; Fukushima, T.; Sun, B.; Sato, Y.; Todo, S. Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis. Ann. N. Y. Acad. Sci. 2003, 995, 171-182.
18. Ren, Y.; Tsui, H. T.; Poon, R. T.; Ng, I. O.; Li, Z.; Chen, Y.; Jiang, G.; Lau, C.; Yu, W. C.; Bacher, M.; Fan, S. T. Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. Int. J. Cancer. 2003, 107, 22-29.
19. Campa, M. J.; Wang, M. Z.; Howard, B.; Fitzgerald, M. C.; Patz, E. F., Jr. Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in nonsmall cell lung cancer. Cancer Res. 2003, 63, 1652-1656.
20. Markert, J. M.; Fuller, C. M.; Gillespie, G. Y.; Bubien, J. K.; McLean, L. A., Hong, R. L.; Lee, K.; Gullans, S. R.; Mapstone, T. B.; Benos, D. J. Differential gene expression profiling in human brain tumors. Physiol. Genomics. 2001, 555, 21-33.
21. Bacher, M.; Schrader, J.; Thompson, N.; Kuschela, K.; Gemsa, D.; Waeber, G.; Schlegel, J. Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme. Am. J. Pathol. 2003, 162, 11-17.
22. Mahutte, N. G.; Matalliotakis, I. M.; Goumenou, A. G.; Koumantakis, G. E.; Vassiliadis, S.; Arid, A. Elevations in peritoneal fluid macrophage migration inhibitory factor are independent of the depth of invasion or stage of endometriosis. Fertil. Steril. 2004, 82, 97-101.
23. Rossel, M.; Brambilla, E.; Billaud, M.; Vuitton, D. A.; Blanc-Jouvan, F.; Biichle, S.; Revillard, J. P. Nonspecific increased serum levels of secretory component in lung tumors: relationship to the gene expression of the transmembrane receptor form. Am. J. Respir. Cell. Mol. Biol. 1993, 9, 341-346.
24. Rossel, M.; Billerey, C.; Bittard, H.; Ksiazek, P.; Alber, D.; Revillard, J. P.; Vuitton, D. A. Alterations in polymeric immunoglobulin receptor expression and secretory component levels in bladder carcinoma. Urol. Res. 1991, 19, 361-366.
25. Sun, Z.; Yang, P. Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. Lancet Oncol. 2004, 5, 182-190.
26. Ryu, J. W.; Kim, H. J.; Lee, Y. S.; Myong, N. H.; Hwang, C. H.; Lee, G. S.; Yom, H. C. The proteomics approach to find biomarkers in gastric cancer. J. Korean Med. Sci. 2003, 18, 505-509.
27. Nejjari, M.; Berthet, V.; Rigot, V.; Laforest, S.; Jacquier, M. F.; Seidah, N. G.; Remy, L.; Bruyneel, E.; Scoazec, J. Y.; Marvaldi, J.; Luis, J. Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model. Am. J. Pathol. 2004, 164, 1925-1933.
28. Choi, H.; Park, C. S.; Kim, B. G.; Cho, J. W.; Park, J. B.; Bae, Y. S.; Bae, D. S. Creatine kinase B is a target molecule of reactive oxygen species in cervical cancer. Mol. Cells. 2001, 12, 412-417.
29. Joseph, J.; Cardesa, A.; Carreras, J. Creatine kinase activity and isoenzymes in lung, colon and liver carcinomas. Br. J. Cancer. 1997, 7776, 600-605.
30. Shields, J. M.; Rogers-Graham, K.; Der, C. J. Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways. J. Biol. Chem. 2002, 277, 9790-9799.
31. Chang, J. W.; Jeon, H. B.; Lee, J. H.; Yoo, J. S.; Chun, J. S.; Kim, J. H.; Yoo, Y. J. Augmented expression of peroxiredoxin I in lung cancer. Biochem. Biophys. Res. Commun. 2001, 289, 507-512.
32. Klade, C. S.; Voss, T.; Krystek, E.; Ahorn, H.; Zatloukal, K.; Pummer, K.; Adolf, G. R. Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics 2001, 1, 890-898.
33. Chen, G.; Gharib, T. G.; Huang, C. C.; Thomas, D. G.; Shedden, K. A.; Taylor, J. M.; Kardia, S. L.; Misek, D. E.; Giordano, T. J.; Iannettoni, M. D.; Orringer, M. B.; Hanash, S. M.; Beer, D. G. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin. Cancer Res. 2002, 8, 2298-2305.
34. Lichtenfels R, Kellner R, Atkins D, Bukur J, Ackermann A, Beck J, Brenner W, Melchior S, Seliger B. Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses. Biochim. Biophys. Acta 2003, 1646, 21-31.
35. Crnogorac-Jurcevic, T.; Efthimiou, E.; Nielsen, T.; Loader, J.; Terris, B.; Stamp, G.; Baron, A.; Scarpa, A.; Lemoine, N. R. Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 2002, 21, 4587-4594.
36. Kuramitsu, Y.; Fujimoto, M.; Tanaka, T.; Ohata, J.; Nakamura, K. Differential expression of phosphatidylethanol-amine-binding protein in rat hepatoma cell lines: analyses of tumor necrosis factor-α-resistant cKDH-8/11 and -sensitive KDH-8/YK cells by two-dimensional gel electrophoresis. Electrophoresis 2000, 21, 660-664.
37. Li, C.; Hong, Y.; Tan, Y.-X.; Zhou, H.; Ai, J.-H.; Li, S.-J.; Zhang, L.; Xia, Q.-C.; Wu, J.-R.; Wang, H.-Y.; Zeng, R. Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity tag and two-dimensional liquid chromatography mass spectrometry. Mol. Cell. Proteomics 2004, 3, 399-409.
38. Srivastava, S.; Verma, M.; Henson, D. E. Biomarkers for early detection of colon cancer. Clin. Cancer Res. 2001, 7, 1118-1126.
39. Vlahou, A.; Schellhammer, P. F.; Mendrinos, S.; Patel, K.; Kondylis, F. I.; Gong, L.; Nasim, S.; Wright, J. G., Jr. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am. J. Pathol. 2001, 153, 1491-1502.
40. Bundred, N. J. Prognostic and predictive factors in breast cancer. Cancer Treat. Rev. 2001, 27, 137-142.
41. Marshall, J.; Kupchak, P.; Zhu, W.; Yantha, J.; Vrees, T.; Furesz, S.; Jacks, K.; Smith, C.; Kireeva, I.; Zhang, R.; Takahashi, M.; Stanton, E.; Jackowski, G. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J. Proteome Res. 2003, 2, 361-372.
42. Wu, S.-L.; Choudhary, G.; Ramström, M.; Bergquist, J.; Hancock, W. S. Evaluation of shotgun sequencing for proteomic analysis of human plasma using HPLC coupled with either ion trap or Fourier transform mass spectrometry. J. Proteome Res. 2003, 2, 383-393.
43. Marshall, J.; Jankowski, A.; Furesz, S.; Kireeva, I.; Barker, L.; Dombrovsky, M.; Zhu, W.; Jacks, K.; Ingratta, L.; Bruin, J.; Kristensen, E.; Zhang, R.; Stanton, E.; Takahashi, M.; Jackowski, G. Human serum proteins preseparated by electrophoresis or chromatography followed by tandem mass spectrometry. J. Proteome Res. 2004, 3, 364-382.
44. Diamandis, E. P. Proteomic patterns in biological fluids: Do they represent the future of cancer diagnostics? Clin. Chem. 2003, 49, 1271-1278.
45. Diamandis, E. P. Analysis of serum proteomic patterns for early cancer diagnosis: Drawing attention to potential problems. J. Nat. Cancer Inst. 2004, 96, 1-2.
46. Diamandis, E. P. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: Opportunities and potential limitations. Mol. Cell. Proteomics 2004, 3, 367-378.